Drug-Stocks im Aufwind
Seite 104 von 160 Neuester Beitrag: 03.03.24 15:26 | ||||
Eröffnet am: | 10.02.13 14:42 | von: SherlockHolm. | Anzahl Beiträge: | 4.987 |
Neuester Beitrag: | 03.03.24 15:26 | von: rolliv | Leser gesamt: | 386.122 |
Forum: | Hot-Stocks | Leser heute: | 319 | |
Bewertet mit: | ||||
Seite: < 1 | ... | 102 | 103 | | 105 | 106 | ... 160 > |
On May 30, 2013 Bio Matrix Scientific Group, Inc (the “Company”) issued to David R. Koos, the Company’s Chairman and Chief Executive Officer, 40,000 shares of the Company’s Series AAA Preferred Stock in satisfaction of $10,000 of accrued but unpaid salary due to David Koos.
-Item 8.01 Other Events
On May 29, 2013 J. Christopher Mizer was dismissed from his position as president of the Company’s wholly owned subsidiary, Regen BioPharma Inc. The position of president of Regen BioPharma Inc. has been assumed by David R. Koos, the Company’s Chairman and Chief Executive Officer.
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=9330861
Der Chart zeigt immer RT
Erkennt man an der Ask-Taxe an der OTC. Zumindest sehe ich das so.